Seven Positive Catalysts Expected to Impact Stock Market on December 22, 2025

Deep News
2025/12/21

1. **Shengxin Lithium Energy (002240)**: Signed a lithium salt product cooperation framework agreement with CALB, under which CALB will purchase 200,000 tons of lithium salt products from the company between 2026 and 2030. Based on current lithium carbonate prices exceeding CNY 100,000 per ton, the deal is estimated to be worth over CNY 20 billion.

2. **Tianqi Lithium (002466)**: Announced the completion and trial operation of the third-phase expansion project for chemical-grade lithium concentrate at Talison. The project, initially planned for completion in Q4 2020 but delayed to 2025, will increase Talison's total lithium concentrate production capacity to 2.14 million tons annually, ensuring stable raw material supply for Tianqi’s lithium chemical plants.

3. **STO Express**: Reported November 2025 operating revenue of CNY 6.028 billion, up 33.10% YoY, with parcel volume reaching 2.502 billion, a 14.67% YoY increase. Average revenue per parcel rose 15.87% to CNY 2.41.

4. **Zhenghai Magnetic Materials (300224)**: Won an international arbitration case against Siemens Gamesa Renewable Energy, which was ordered to pay EUR 1.1951 million in legal and expert fees. The ruling is expected to positively impact the company’s financial performance.

5. **China Kings Resources Group (603505)**: Plans to acquire a 15.7147% stake in Noah Fluorochemicals for CNY 257 million, becoming its second-largest shareholder.

6. **Zhongmi Holdings**: Stated that no new orders for nuclear main pump mechanical seals have been secured in 2025 due to stringent safety requirements and long project cycles in the nuclear sector. However, the company remains optimistic about future opportunities.

7. **Gansu Shangfeng Cement (000672)**: Announced that its investee, Yuexin Semiconductor, has filed for a创业板 (ChiNext) IPO, which was accepted by the Shenzhen Stock Exchange on December 19.

*Disclaimer: This content is for informational purposes only and does not constitute investment advice.*

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10